These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 22336201)

  • 1. Relationship between chromatin structure and sensitivity to molecularly targeted auger electron radiation therapy.
    Terry SY; Vallis KA
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1298-305. PubMed ID: 22336201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidermal growth factor receptor inhibition modulates the nuclear localization and cytotoxicity of the Auger electron emitting radiopharmaceutical 111In-DTPA human epidermal growth factor.
    Bailey KE; Costantini DL; Cai Z; Scollard DA; Chen Z; Reilly RM; Vallis KA
    J Nucl Med; 2007 Sep; 48(9):1562-70. PubMed ID: 17704253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ErbB-2 blockade and prenyltransferase inhibition alter epidermal growth factor and epidermal growth factor receptor trafficking and enhance (111)In-DTPA-hEGF Auger electron radiation therapy.
    Cornelissen B; Darbar S; Hernandez R; Kersemans V; Tullis I; Barber PR; Smart S; Vojnovic B; Reilly R; Vallis KA
    J Nucl Med; 2011 May; 52(5):776-83. PubMed ID: 21498540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between induction of phosphorylated H2AX and survival in breast cancer cells exposed to 111In-DTPA-hEGF.
    Cai Z; Chen Z; Bailey KE; Scollard DA; Reilly RM; Vallis KA
    J Nucl Med; 2008 Aug; 49(8):1353-61. PubMed ID: 18632822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Amplification of DNA damage by a γH2AX-targeted radiopharmaceutical.
    Cornelissen B; Darbar S; Kersemans V; Allen D; Falzone N; Barbeau J; Smart S; Vallis KA
    Nucl Med Biol; 2012 Nov; 39(8):1142-51. PubMed ID: 22819196
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects and normal tissue toxicity of 111In-labeled epidermal growth factor administered to athymic mice bearing epidermal growth factor receptor-positive human breast cancer xenografts.
    Chen P; Cameron R; Wang J; Vallis KA; Reilly RM
    J Nucl Med; 2003 Sep; 44(9):1469-78. PubMed ID: 12960194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 111In-labeled EGF is selectively radiotoxic to human breast cancer cells overexpressing EGFR.
    Reilly RM; Kiarash R; Cameron RG; Porlier N; Sandhu J; Hill RP; Vallis K; Hendler A; Gariépy J
    J Nucl Med; 2000 Mar; 41(3):429-38. PubMed ID: 10716315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multifunctional block copolymer micelles for the delivery of 111In to EGFR-positive breast cancer cells for targeted Auger electron radiotherapy.
    Fonge H; Lee H; Reilly RM; Allen C
    Mol Pharm; 2010 Feb; 7(1):177-86. PubMed ID: 19924993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of the EGFR density of breast cancer cells on nuclear importation, in vitro cytotoxicity, and tumor and normal-tissue uptake of [111In]DTPA-hEGF.
    Hu M; Scollard D; Chan C; Chen P; Vallis K; Reilly RM
    Nucl Med Biol; 2007 Nov; 34(8):887-96. PubMed ID: 17998090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preclinical pharmacokinetic, biodistribution, toxicology, and dosimetry studies of 111In-DTPA-human epidermal growth factor: an auger electron-emitting radiotherapeutic agent for epidermal growth factor receptor-positive breast cancer.
    Reilly RM; Chen P; Wang J; Scollard D; Cameron R; Vallis KA
    J Nucl Med; 2006 Jun; 47(6):1023-31. PubMed ID: 16741313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suberoylanilide hydroxamic acid, an inhibitor of histone deacetylase, enhances radiosensitivity and suppresses lung metastasis in breast cancer in vitro and in vivo.
    Chiu HW; Yeh YL; Wang YC; Huang WJ; Chen YA; Chiou YS; Ho SY; Lin P; Wang YJ
    PLoS One; 2013; 8(10):e76340. PubMed ID: 24130769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of non-biologically active truncated EGF (EGFt) and full-length hEGF for delivery of Auger electron-emitting 111In to EGFR-positive breast cancer cells and tumor xenografts in athymic mice.
    Panosa C; Fonge H; Ferrer-Batallé M; Menéndez JA; Massaguer A; De Llorens R; Reilly RM
    Nucl Med Biol; 2015 Dec; 42(12):931-8. PubMed ID: 26385534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suberoylanilide hydroxamic acid affects γH2AX expression in osteosarcoma, atypical teratoid rhabdoid tumor and normal tissue cell lines after irradiation.
    Blattmann C; Oertel S; Thiemann M; Weber KJ; Schmezer P; Zelezny O; Lopez Perez R; Kulozik AE; Debus J; Ehemann V
    Strahlenther Onkol; 2012 Feb; 188(2):168-76. PubMed ID: 22249335
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Computational analysis of the number, area and density of gamma-H2AX foci in breast cancer cells exposed to (111)In-DTPA-hEGF or gamma-rays using Image-J software.
    Cai Z; Vallis KA; Reilly RM
    Int J Radiat Biol; 2009 Mar; 85(3):262-71. PubMed ID: 19296344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiosensitization of glioblastoma cells using a histone deacetylase inhibitor (SAHA) comparing carbon ions with X-rays.
    Barazzuol L; Jeynes JC; Merchant MJ; Wéra AC; Barry MA; Kirkby KJ; Suzuki M
    Int J Radiat Biol; 2015 Jan; 91(1):90-8. PubMed ID: 25040548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methotrexate, paclitaxel, and doxorubicin radiosensitize HER2-amplified human breast cancer cells to the Auger electron-emitting radiotherapeutic agent (111)In-NLS-trastuzumab.
    Costantini DL; Villani DF; Vallis KA; Reilly RM
    J Nucl Med; 2010 Mar; 51(3):477-83. PubMed ID: 20150272
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in histone acetylation following exposure to
    Tian XL; Lu X; Feng JB; Cai TJ; Li S; Tian M; Liu QJ
    Radiat Environ Biophys; 2018 Aug; 57(3):215-222. PubMed ID: 29774413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of EGF and MAb 528 labeled with 111In for imaging human breast cancer.
    Reilly RM; Kiarash R; Sandhu J; Lee YW; Cameron RG; Hendler A; Vallis K; Gariépy J
    J Nucl Med; 2000 May; 41(5):903-11. PubMed ID: 10809207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antiproliferative effects of (111)In-DTPA-hEGF, chemotherapeutic agents and gamma-radiation on EGFR-positive breast cancer cells.
    Chen P; Mrkobrada M; Vallis KA; Cameron R; Sandhu J; Hendler A; Reilly RM
    Nucl Med Biol; 2002 Aug; 29(6):693-9. PubMed ID: 12234595
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decitabine and suberoylanilide hydroxamic acid (SAHA) inhibit growth of ovarian cancer cell lines and xenografts while inducing expression of imprinted tumor suppressor genes, apoptosis, G2/M arrest, and autophagy.
    Chen MY; Liao WS; Lu Z; Bornmann WG; Hennessey V; Washington MN; Rosner GL; Yu Y; Ahmed AA; Bast RC
    Cancer; 2011 Oct; 117(19):4424-38. PubMed ID: 21491416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.